Estimation of carbon footprint in nuclear medicine: illustration of a french department

Purpose: In order to limit climate changes, we need to reduce the carbon footprint of human activities, including those due to health systems. We performed an estimation of the carbon footprint of our nuclear medicine department using a methodology developed with the help of a specialized consulting firm. Methods: The estimate of greenhouse gas (GHG) emissions comprises direct and indirect emissions. Direct emissions are due to fuels consumption (by the hospital and by hospital’s vehicles), refr

Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas

Objective: This study aims to calculate the global warming potential, in carbon dioxide (CO2) equivalent emissions, from all in-scope activities involved in phase 1, 2, 3 and 4 clinical trials spanning multiple disease areas. Design: The study design involved a retrospective analysis of completed clinical trials. Setting: Select set of seven clinical trials conducted between 2018 and 2023 and sponsored by Johnson & Johnson Innovative Medicine: TMC114FD1HTX1002, 77242113PSO2001, 42756493BLC2002,